# Genetic and Pharmacologic Inhibition of β-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/genetic-and-pharmacologic-inhibition-of-catenin-targets-imatinib-resistant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Florian H. Heidel,Lars Bullinger,Zhaohui Feng,Zhu Wang,Tobias Neff,Lauren Stein,Demetrios Kalaitzidis,Steven Lane,Scott A. Armstrong |
| Citations | 225 |
| DOI | 10.1016/j.stem.2012.02.017 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.cell.com/article/S1934590912000768/pdf |
| OpenAlex ID | https://openalex.org/W2066766199 |
| PMID | 22482506 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Steven Lane](https://scholariq.org/researchers/steven-lane/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.